Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.

J Am Heart Assoc · 2014 · PMC4187510 · PMID 24732921

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

We also observed a decreasing trend in early but not discharge P2Y12 antagonist use over time among NSTEMI patients, suggesting that clinicians may be delaying the use and choice of P2Y12 antagonist until a revascularization strategy has been selected.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.